PDCD1 and cancer: Experiments on antibiotic-treated or germ-free mice administered fecal microbiota transplantation from cancer patients on anti-PD-1 therapy showed resistance to therapy in mice that received FMT from non-responders and effective antitumor activity in mice that received FMT from responders (193, 225, 226, 259).